Butterfly Network (NYSE:BFLY – Get Free Report) is expected to be announcing its Q3 2026 results before the market opens on Thursday, October 29th. Analysts expect Butterfly Network to announce earnings of ($0.0353) per share and revenue of $28.37 million for the quarter. Interested persons may review the information on the company’s upcoming Q3 2026 earnings overview page for the latest details on the call scheduled for Thursday, October 29, 2026 at 8:00 AM ET.
Butterfly Network (NYSE:BFLY – Get Free Report) last announced its quarterly earnings results on Thursday, July 30th. The company reported ($0.01) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.04) by $0.03. Butterfly Network had a negative net margin of 66.74% and a negative return on equity of 33.99%. The firm had revenue of $32.61 million during the quarter, compared to analysts’ expectations of $29.16 million. On average, analysts expect Butterfly Network to post ($0.18) EPS for the current fiscal year and ($0.14) EPS for the next fiscal year.
Butterfly Network Stock Performance
Shares of NYSE BFLY opened at $7.09 on Thursday. The firm has a 50 day moving average price of $8.31 and a two-hundred day moving average price of $6.87. The stock has a market cap of $1.89 billion, a P/E ratio of -24.47 and a beta of 2.04. Butterfly Network has a 52-week low of $1.90 and a 52-week high of $10.21.
Wall Street Analyst Weigh In
BFLY has been the topic of a number of recent research reports. Weiss Ratings reiterated a “sell (d-)” rating on shares of Butterfly Network in a report on Monday, August 3rd. TD Cowen restated a “buy” rating and issued a $10.00 price objective on shares of Butterfly Network in a report on Friday, September 11th. Needham & Company LLC initiated coverage on Butterfly Network in a research report on Tuesday, September 22nd. They set a “buy” rating and a $10.00 target price for the company. Canaccord Genuity Group started coverage on Butterfly Network in a research report on Monday, October 12th. They set a “buy” rating and a $10.00 target price for the company. Finally, Evercore initiated coverage on Butterfly Network in a report on Tuesday, September 29th. They set an “outperform” rating and a $15.00 target price on the stock. One equities research analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, Butterfly Network presently has an average rating of “Moderate Buy” and an average price target of $8.75.
Get Our Latest Stock Report on BFLY
Insider Activity at Butterfly Network
In other Butterfly Network news, insider Steve Cashman sold 140,112 shares of the firm’s stock in a transaction on Friday, September 4th. The shares were sold at an average price of $7.30, for a total value of $1,022,817.60. Following the completion of the sale, the insider directly owned 1,490,295 shares in the company, valued at approximately $10,879,153.50. This trade represents a 8.59% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Louise Phanstiel purchased 115,200 shares of the firm’s stock in a transaction on Friday, August 14th. The stock was bought at an average cost of $8.68 per share, with a total value of $999,936.00. Following the completion of the purchase, the director owned 300,461 shares of the company’s stock, valued at approximately $2,608,001.48. This represents a 62.18% increase in their position. The disclosure for this purchase is available in the SEC filing. Insiders have sold 354,707 shares of company stock worth $2,967,211 over the last ninety days. 21.99% of the stock is owned by corporate insiders.
Butterfly Network Company Profile
Butterfly Network, Inc develops portable medical imaging technology designed to make ultrasound more accessible across hospitals, clinics, emergency-care settings and other care environments. The company’s core products use a semiconductor-based ultrasound-on-chip platform, replacing conventional ultrasound systems’ large arrays of piezoelectric transducers with a compact, software-driven probe.
Its product portfolio includes the Butterfly iQ, iQ+, and iQ3 handheld ultrasound systems, which connect to compatible mobile devices and provide imaging across multiple clinical applications.
Read More
- Five stocks we like better than Butterfly Network
- GM Beat and Added a $20 Billion Buyback—Why Did the Stock Fall?
- Intercepting Growth: Karman Secures $218M Lockheed Martin Deal
- Tech Stocks Took a Hit—These 2 Pharma Stocks Are Near New Highs
- Chip Stocks Have Pulled Back—Here’s How 3 Semiconductor ETFs Stack Up for Investors
Receive News & Ratings for Butterfly Network Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Butterfly Network and related companies with MarketBeat.com's FREE daily email newsletter.
